Axalta (NYSE:AXTA) and AkzoNobel (OTCQX:AKZOF) to merge in an all-stock deal mixing together a coatings giant valued at US$25 billion.
Theralase’s (TSXV:TLT) Ruvidar and Rutherrin show strong potential in treating bladder cancer, solid tumors, and HSV-1.
Almonty Industries: New all-time high soon? Oppenheimer analysts see several catalysts for rising prices in Almonty’s (TSX:AII) stock. In their latest update, they recommend buying the ...
Gold Terra Resource (TSXV:YGT) secures financing commitments from David Harquail and Eric Sprott totaling C$6.3 million.
TORONTO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE/TSX: MUX) today announced its third quarter (Q3) and year-to-date (9M) results for the period ended September 30, 2025, and reported on its ...
Join the discussion: Find out what the Bullboards are saying about Nuclear Vision and check out Stockhouse’s stock forums and message boards. Stockhouse does not provide investment advice or ...
Westhaven Gold (TSXV:WHN) intends to raise C$3.16 million through a non-brokered private placement, including expected investments from Eric Sprott and Earthlabs (TSXV:SPOT). The company will issue up ...
Gold producer Talisker Resources is negotiating a seven-year ore purchase agreement with Ocean Partners UK for up to 1,500 tons per day.
In September 2025, Pasofino’s geological team returned to the field with renewed focus. Their exploration efforts targeted areas adjacent to the Tuzon and Dugbe F deposits—regions that ...
A seismic shift is coming to the gold mining industry Investors and industry insiders alike are watching closely as a breakthrough clean-tech solution enters the public market—one that promises to ...
Management, aligned with 21 per cent insider ownership, expects its air business to ramp up to $40 million in revenue by 2026, which is more than twice total company revenue in 2024, as it deploys $57 ...
This peer-reviewed publication provides strong support that Ruvidar® is more effective in the treatment of HSV-1 than either Acyclovir® or Metformin®, even without ...